US HB4813 | 2021-2022 | 117th Congress
Status
Sponsorship: Bipartisan Bill
Status: Introduced on July 29 2021 - 25% progression, died in committee
Action: 2021-07-30 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on July 29 2021 - 25% progression, died in committee
Action: 2021-07-30 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To limit the price of insulin drugs accessible for participants, beneficiaries, and enrollees enrolled in group or individual health insurance coverage and group health plans and for uninsured individuals who have diabetes, and for other purposes.
Title
Matt’s Act
Sponsors
| Rep. Jeff Fortenberry [R-NE] | Rep. Angela Craig [D-MN] |
History
| Date | Chamber | Action |
|---|---|---|
| 2021-07-30 | House | Referred to the Subcommittee on Health. |
| 2021-07-29 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Education and Labor, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
| 2021-07-29 | House | Introduced in House |
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/117th-congress/house-bill/4813/all-info |
| Text | https://www.congress.gov/117/bills/hr4813/BILLS-117hr4813ih.pdf |
